| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100624C002 |
2.13 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100624C005 |
2.62 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100624C009 |
2.81 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100624C013 |
2.18 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100624C017 |
3.16 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100624C021 |
3.19 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100624C025 |
4.75 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100624C029 |
2.95 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100624C001 |
1.66 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100624C003 |
1.81 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100624C007 |
2.27 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100624C011 |
2.43 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100624C015 |
2.9 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100624C019 |
3.21 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100624C023 |
2.8 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100624C027 |
3.37 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100624C006 |
2.32 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100624C010 |
2.01 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100624C014 |
2.78 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100624C018 |
1.98 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100624C022 |
2.88 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100624C026 |
4.09 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100624C030 |
2.83 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100624C004 |
3.24 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100624C008 |
3.56 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100624C012 |
2.74 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100624C016 |
3.04 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100624C020 |
3.05 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100624C024 |
3.54 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100624C028 |
4.49 |
pmol/ug DNA |